ALISON HALL: Open Payments
NPI 1376617050 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,794 in 137 payments from 18 companies in 2025. Trend: 2023 $1,967 · 2024 $2,807 · 2025 $2,794
Food & beverage: $2,709Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $619 |
| Janssen Biotech, Inc. | 19 | $430 |
| Ardelyx, Inc. | 12 | $357 |
| GENZYME CORPORATION | 8 | $225 |
| Ipsen Biopharmaceuticals, Inc | 10 | $210 |
| Madrigal Pharmaceuticals | 7 | $195 |
| Aimmune Therapeutics, Inc. | 10 | $167 |
| Regeneron Healthcare Solutions, Inc. | 5 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $78 |
| Lilly USA, LLC | 4 | $75 |
Products named: TREMFYA, IBSRELA, DUPIXENT, RINVOQ, IQIRVO, REZDIFFRA, SKYRIZI, VOWST.
Industry payments across AL — which companies pay providers there.
